CORRESP 1 filename1.htm

 

September 28, 2023

 

VIA EDGAR

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Re: Sonnet BioTherapeutics Holdings, Inc.
  Registration Statement on Form S-1
  File No. 333-274581

 

Ladies and Gentlemen:

 

Sonnet BioTherapeutics Holdings, Inc. hereby requests that its acceleration request dated September 28, 2023 be withdrawn. Please call Tracy F. Buffer of Lowenstein Sandler LLP at (973) 597-2434 with any questions.

 

  Sincerely,
   
  SONNET BIOTHERAPEUTICS HOLDINGS, INC.
   
  By: /s/ Pankaj Mohan
  Name: Pankaj Mohan
  Title: Chief Executive Officer